MX01LA010006
MX01LA010006
GENOMMA LAB INTERNACIONAL SAB
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 17.541.157.000 | 18.606.903.000 | 5.7% |
| Cost of Revenue | 6.519.025.000 | 6.675.859.000 | 2.3% |
| Gross Profit | 11.022.132.000 | 11.931.044.000 | 7.6% |
| 7.265.771.000 | 8.025.619.000 | 9.5% | |
| Operating Income | 3.756.361.000 | 3.905.425.000 | 3.8% |
| Pretax Income | 2.433.749.000 | 2.891.092.000 | 15.8% |
| Net Income Common Stockholders | 1.613.998.000 | 1.493.122.000 | 8.1% |
| -- | -- | -- | |
| -- | -- | -- |